Report Detail
Global Atropine Market Growth 2019-2024
- RnM2906510 |
- 08 February, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group and CR Double-Crane.
Compared to 2016, Atropine market decreased revenue by 5.69 percent to $549.60 million worldwide in 2017 from $582.76 million in 2016. As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of long-term effects of market behavior.
The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.
According to this study, over the next five years the Atropine market will register a -1.6% CAGR in terms of revenue, the global market size will reach US$ 500 million by 2024, from US$ 550 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Atropine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application, key manufacturers and key regions and countries.
This study considers the Atropine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Injection
Drop
Gel
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Gastrointestinal
Ophthalmology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng Group
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Atropine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Atropine market by identifying its various subsegments.
Focuses on the key global Atropine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atropine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Atropine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Atropine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Atropine Consumption 2014-2024
- 2.1.2 Atropine Consumption CAGR by Region
- 2.2 Atropine Segment by Type
- 2.2.1 Injection
- 2.2.2 Drop
- 2.2.3 Gel
- 2.3 Atropine Consumption by Type
- 2.3.1 Global Atropine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Atropine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Atropine Sale Price by Type (2014-2019)
- 2.4 Atropine Segment by Application
- 2.4.1 Gastrointestinal
- 2.4.2 Ophthalmology
- 2.4.3 Other
- 2.5 Atropine Consumption by Application
- 2.5.1 Global Atropine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Atropine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Atropine Sale Price by Application (2014-2019)
3 Global Atropine by Players
- 3.1 Global Atropine Sales Market Share by Players
- 3.1.1 Global Atropine Sales by Players (2017-2019)
- 3.1.2 Global Atropine Sales Market Share by Players (2017-2019)
- 3.2 Global Atropine Revenue Market Share by Players
- 3.2.1 Global Atropine Revenue by Players (2017-2019)
- 3.2.2 Global Atropine Revenue Market Share by Players (2017-2019)
- 3.3 Global Atropine Sale Price by Players
- 3.4 Global Atropine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Atropine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Atropine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Atropine by Regions
- 4.1 Atropine by Regions
- 4.1.1 Global Atropine Consumption by Regions
- 4.1.2 Global Atropine Value by Regions
- 4.2 Americas Atropine Consumption Growth
- 4.3 APAC Atropine Consumption Growth
- 4.4 Europe Atropine Consumption Growth
- 4.5 Middle East & Africa Atropine Consumption Growth
5 Americas
- 5.1 Americas Atropine Consumption by Countries
- 5.1.1 Americas Atropine Consumption by Countries (2014-2019)
- 5.1.2 Americas Atropine Value by Countries (2014-2019)
- 5.2 Americas Atropine Consumption by Type
- 5.3 Americas Atropine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Atropine Consumption by Countries
- 6.1.1 APAC Atropine Consumption by Countries (2014-2019)
- 6.1.2 APAC Atropine Value by Countries (2014-2019)
- 6.2 APAC Atropine Consumption by Type
- 6.3 APAC Atropine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Atropine by Countries
- 7.1.1 Europe Atropine Consumption by Countries (2014-2019)
- 7.1.2 Europe Atropine Value by Countries (2014-2019)
- 7.2 Europe Atropine Consumption by Type
- 7.3 Europe Atropine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Atropine by Countries
- 8.1.1 Middle East & Africa Atropine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Atropine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Atropine Consumption by Type
- 8.3 Middle East & Africa Atropine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Atropine Distributors
- 10.3 Atropine Customer
11 Global Atropine Market Forecast
- 11.1 Global Atropine Consumption Forecast (2019-2024)
- 11.2 Global Atropine Forecast by Regions
- 11.2.1 Global Atropine Forecast by Regions (2019-2024)
- 11.2.2 Global Atropine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Atropine Forecast by Type
- 11.8 Global Atropine Forecast by Application
12 Key Players Analysis
- 12.1 C²PHARMA
- 12.1.1 Company Details
- 12.1.2 Atropine Product Offered
- 12.1.3 C²PHARMA Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 C²PHARMA News
- 12.2 RESONANCE LABORATORIES
- 12.2.1 Company Details
- 12.2.2 Atropine Product Offered
- 12.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 RESONANCE LABORATORIES News
- 12.3 ROLABO OUTSOURCING
- 12.3.1 Company Details
- 12.3.2 Atropine Product Offered
- 12.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 ROLABO OUTSOURCING News
- 12.4 Minsheng Group
- 12.4.1 Company Details
- 12.4.2 Atropine Product Offered
- 12.4.3 Minsheng Group Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Minsheng Group News
- 12.5 CR Double-Crane
- 12.5.1 Company Details
- 12.5.2 Atropine Product Offered
- 12.5.3 CR Double-Crane Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 CR Double-Crane News
- 12.6 HENAN PURUI
- 12.6.1 Company Details
- 12.6.2 Atropine Product Offered
- 12.6.3 HENAN PURUI Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 HENAN PURUI News
- 12.7 Albany Molecular Research
- 12.7.1 Company Details
- 12.7.2 Atropine Product Offered
- 12.7.3 Albany Molecular Research Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Albany Molecular Research News
- 12.8 Alchem International
- 12.8.1 Company Details
- 12.8.2 Atropine Product Offered
- 12.8.3 Alchem International Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Alchem International News
- 12.9 SAURAV CHEMICALS
- 12.9.1 Company Details
- 12.9.2 Atropine Product Offered
- 12.9.3 SAURAV CHEMICALS Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 SAURAV CHEMICALS News
- 12.10 Katsura Chemical
- 12.10.1 Company Details
- 12.10.2 Atropine Product Offered
- 12.10.3 Katsura Chemical Atropine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Katsura Chemical News
- 12.11 Hangzhou Vega
- 12.12 Wuhan senwayer century
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Atropine . Industry analysis & Market Report on Atropine is a syndicated market report, published as Global Atropine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Atropine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
